Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG-Reference-Cited by-同舟云学术

Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG

Published:2010-05-13 Issue:5 Volume:5 Page:e10626
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

van den Boorn Jasper G.,Konijnenberg Debby,Tjin Esther P. M.,Picavet Daisy I.,Meeuwenoord Nico J.,Filippov Dmitri V.,van der Veen J. P. Wietze,Bos Jan D.,Melief Cornelis J. M.,Luiten Rosalie M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Spontaneous regression of primary malignant melanomas with regional metastases.;JL Smith Jr;Cancer,1965

2. Influence of melanosome dynamics on melanoma drug sensitivity.;KG Chen,2009

3. Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.;RS Bart;Cancer Res,1980

4. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.;JM Kirkwood;J Clin Oncol,1996

5. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.;SA Rosenberg;J Exp Med,1985

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erzhiwan Ameliorates Restraint Stress- and Monobenzone-Induced Depigmentation in Mice by Inhibiting Macrophage Migration Inhibitory Factor and 8-Hydroxy-2-Deoxyguanosine;Clinical, Cosmetic and Investigational Dermatology;2024-01

2. pyHeart4Fish: Chamber-specific heart phenotype quantification of zebrafish in high-content screens;Frontiers in Cell and Developmental Biology;2023-04-11

3. Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect;Cancers;2021-08-05

4. Towards a scaled-up T cell-mediated cytotoxicity assay in 3D cell culture using microscopy;2019-11-14

5. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data;Molecular Medicine;2019-06-20